For instance, deregulated activation of protein kinases and phosphatases, e.g., ErbB2, EGFR, MAPK, VEGF, mTOR, have become one of the most widely studied tumor therapeutic targets [51,112,113,114,115]. The gene discussed is MTOR; the disease is neoplasm.